8STG
Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.
| Version Number | Version Date | Version Type/Reason | Version Change | Revised CIF Category | |
|---|---|---|---|---|---|
| 1.0 | 2023-06-07 | Initial release | |||
| 1.1 | 2023-06-14 | Database references | citation, citation_author | ||
| 1.2 | 2023-09-13 | Data collection, Database references | chem_comp_atom, chem_comp_bond, citation | Download | |
| 2.0 | 2023-09-20 | Atomic model, Data collection, Derived calculations, Non-polymer description, Structure summary | atom_site, chem_comp, chem_comp_atom, chem_comp_bond, entity, pdbx_entity_nonpoly | Download | |
| 3.0 | 2023-10-18 | Coordinate replacement / Ligand geometry | Advisory, Atomic model, Data collection, Derived calculations, Refinement description | atom_site, pdbx_validate_close_contact, pdbx_validate_torsion, refine, refine_ls_restr, refine_ls_restr_ncs, refine_ls_shell, software, struct_conn, struct_ncs_dom, struct_ncs_dom_lim, struct_ncs_oper | |
| 3.1 | 2023-10-25 | Refinement description | pdbx_initial_refinement_model | Download |
